Related Experiment Videos

Effects of LDL apheresis on restenosis after angioplasty

S Kanemitsu1, N Tekekoshi, E Murakami

  • 1Department of Cardiology, Kanazawa Medical University, Ishikawa, Japan.

Chemistry and Physics of Lipids
|January 1, 1994
PubMed

Insights

Long-term low-density lipoprotein (LDL) apheresis effectively lowers cholesterol and Lp(a) in hypercholesterolemia patients post-PTCA. This therapy helps prevent recurrent stenosis after percutaneous transluminal coronary angioplasty.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Interventional Cardiology

Background:

  • Hypercholesterolemia poses risks for cardiovascular events.
  • Percutaneous transluminal coronary angioplasty (PTCA) is a common intervention for coronary artery disease.
  • Recurrent stenosis after PTCA remains a clinical challenge.

Purpose of the Study:

  • To evaluate the efficacy of long-term LDL apheresis in managing hypercholesterolemia.
  • To assess the impact of LDL apheresis on serum lipids, including cholesterol, LDL-cholesterol, and Lp(a).
  • To determine the role of LDL apheresis in preventing recurrent stenosis following PTCA.

Main Methods:

  • Long-term maintenance LDL apheresis therapy was administered.
  • Patients with hypercholesterolemia who had undergone PTCA were included.
  • Serum levels of cholesterol, LDL-cholesterol, and Lp(a) were monitored.

Main Results:

  • LDL apheresis significantly reduced serum cholesterol levels.
  • LDL apheresis led to a significant reduction in LDL-cholesterol.
  • Significant reductions in serum Lp(a) levels were observed.
  • LDL apheresis demonstrated efficacy in preventing recurrent stenosis post-PTCA.

Conclusions:

  • Long-term LDL apheresis is an effective treatment for hypercholesterolemia.
  • LDL apheresis successfully lowers key serum lipids.
  • LDL apheresis therapy is beneficial in preventing recurrent stenosis after PTCA.

Related Concept Videos